Dec 23, 2021· Comment from Association for Accessible Medicines (AAM)· FDA-2021-D-0432-0009
Comments from the Association for Accessible Medicines regarding Docket No. FDA-2021-D-0432: Microbiological Quality Considerations in Non-Sterile Drug Manufacturing, Draft Guidance for Industry